Company Monitoring Page for Amgen

job ratings (see below graph) for Amgen

latest headlines for company on cafepharma

Amgen’s Phase 3 win in lung cancer puts pressure on Mirati bid for speedy FDA nod
MedCity News
Wed, 08/31/22 - 10:23 am
Tags:
Amgen, Lumakras, non-small cell lung cancer, clinical trials
Amgen, amid $10B fight with IRS, lands in Senate committee's tax probe
Fierce Pharma
Fri, 08/12/22 - 10:17 am
Tags:
Amgen, taxes, IRS, Senate
Plaque psoriasis and psoriatic arthritis: trials to watch in 2022
Clinical Trials Arena
Tue, 08/9/22 - 06:32 am
Tags:
clinical trials, psoriasis, psoriatic arthritis, Lipidor, AKP-02, Amgen, ABP-654, Hengyi, HPP-737, Galapagos, Jyseleca
World Lung – Toxicity scuppers Amgen’s first-line lung hopes
EP Vantage
Mon, 08/8/22 - 09:53 am
Tags:
Amgen, World Lung, Lumakras, non-small cell lung cancer
Amgen takes BiTEs out of pipeline, dropping BCMA, PSMA assets in light of data and competition
Fierce Biotech
Fri, 08/5/22 - 10:42 am
Tags:
Amgen, BCMA, PSMA, Multiple Myeloma, bispecific antibodies
Amgen, on an M&A spree, inks $3.7B ChemoCentryx buyout to boost inflammatory disease presence
Fierce Pharma
Thu, 08/4/22 - 12:10 pm
Tags:
Amgen, M&A, patent cliff, ChemoCentryx
Weeks after starting, Amgen flashes yellow light on PhIII of $400M eczema bet
Endpoints
Thu, 08/4/22 - 11:03 am
Tags:
Amgen, Kyowa Kirin, clinical trials, AMG 451, atopic dermatitis
Drugmakers leap back into fading heart drug market
Beckers Hospital Review
Thu, 07/28/22 - 06:40 pm
Tags:
Bristol Myers Squibb, Novartis, Merck, Alnylam Pharmaceuticals, Amgen, hypertension, cholesterol
Big Pharmas Amgen, BMS shield BigHat from stormy market with $75M funding
Fierce Biotech
Wed, 07/20/22 - 10:01 am
Tags:
BigHat Biosciences, funding, Amgen, Bristol Myers Squibb
Amgen, GSK, Regenxbio and others urge SCOTUS to review 'damaging' decision on biomedical patents
Endpoints
Tue, 07/19/22 - 10:01 pm
Tags:
Amgen, GSK, Regenxbio, Supreme Court, innovation, patents
Amgen's blockbuster hopeful Lumakras sees slower than expected sales in latest data, analyst says
Endpoints
Mon, 07/11/22 - 05:53 pm
Tags:
Amgen, non-small cell lung cancer, Lumakras
Amgen-backed Kernal Biologics pops off with $25M for mRNA platform
Fierce Biotech
Thu, 07/7/22 - 06:22 pm
Tags:
Kernal Biologics, MRNA, Amgen, funding
Amgen sells its Turkish manufacturing arm for $135M
Endpoints
Wed, 06/29/22 - 05:35 pm
Tags:
Amgen, Turkey, M&A, Gensenta, drug manufacturing
Amgen takes next step with its China ambitions, out-licensing drugs to Fosun Pharma
Endpoints
Mon, 06/27/22 - 06:58 pm
Tags:
Amgen, China, Fosun Pharmaceutical
As biosimilars gain steam, Amgen exec lays out its Humira copycat plans
Fierce Pharma
Wed, 06/22/22 - 06:57 pm
Tags:
Amgen, Humira, biosimilars
Cytokinetics aims to become the Vertex of cardiovascular disease
EP Vantage
Thu, 06/16/22 - 10:19 am
Tags:
Cytokinetics, Amgen, heart failure, Omecamtiv Mecarbil, cardiovascular disease
ASCO 2022 – the spirit of Rova-T struggles to live on
EP Vantage
Tue, 06/7/22 - 10:19 am
Tags:
ASCO 2022, Rova-T, AbbVie, Harpoon Therapeutics, Amgen, Boehringer Ingelheim
ASCO: It's all tied up? Mirati's KRAS data are 'identical' to Amgen's, researcher says
Fierce Biotech
Mon, 06/6/22 - 10:33 am
Tags:
ASCO 2022, Mirati Therapeutics, Amgen, Lumakras, adagrasib, lung cancer
Regeneron's cholesterol drug war heats up with lawsuit over Amgen's 'illegal' bundling scheme
Fierce Pharma
Wed, 06/1/22 - 07:36 pm
Tags:
Regeneron, Amgen, FDA, antitrust, legal, Repatha, Praluent
Amgen eyes swift move to ph3 for cardiovascular drug olpasiran
Pharmaforum
Wed, 06/1/22 - 09:33 am
Tags:
Amgen, olpasiran, Novartis, clinical trials, cardiovascular disease

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.